Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT02938858
Eligibility Criteria:
Inclusion Criteria:
* Newly-diagnosed APL (either de novo or therapy-related) based on cytologic criteria and confirmed by the presence of the t(15;17) translocation and/or by the detection of the fusion transcript PML/RARα.
* Non-high-risk APL (White Blood Count \< 10000/μl at presentation)
* Age ≤ 70 years
Exclusion Criteria:
* Relapsed APL
* Newly-diagnosed High-risk APL (White Blood Count \> 10000/μl at presentation)
* Age \> 70 years
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
70 Years
Study:
NCT02938858
Study Brief:
Protocol Section:
NCT02938858